Usefulness of lymphocyte subset change as an indicator for predicting survival time and effectiveness of treatment with the immunopotentiator lentinan.

Abstract:

:The usefulness of lymphocyte subset change as an indicator for predicting survival time and the effectiveness of combined treatment with an immunopotentiator, lentinan, and carboplatin (CBDCA) were investigated. Of 13 patients with advanced unresectable cancer entered in this study, 9 were administered 2 mg/body lentinan and 450 mg/m2 CBDCA, and 4 were administered a single modality of CBDCA. The mean survival time of all 13 cases was 9.89 months. Lymphocyte subsets of CD11(-)CD8(+), CD11(+)CD8(+), CD57(-)CD16(+) and CD57(+)CD16(+,-) were measured by two-color flow cytometry. In five cases surviving longer than 9.89 months, CD11(-)CD8(+)/CD11(+)CD8(+) on post-treatment showed an increase two-fold higher than on pre-treatment, but in all cases surviving less than 9.89 months the rate on post-treatment did not increase two fold higher than on pre-treatment. The mean (1.78) of (post-treatment/pre-treatment) ratios of CD57(-)CD16(+)/CD57(+) in long survival cases was significantly higher (p < 0.01) than that (0.46) in short survival cases. Moreover, the mean of (post-treatment/pre-treatment) ratios of CD11(-)CD8(+)/CD11(+)CD8(+) and CD57(-) CD16(+)/CD57(+) showed a good correlation with survival time. These results indicate that changes of lymphocyte subsets of killer T cell/suppressor T cell and natural killer cell on posttreatment compared to pre-treatment are clinically useful indicators for predicting and monitoring the effectiveness of combined treatment with lentinan and CBDCA.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Matsuoka H,Yano K,Seo Y,Saito T,Tomoda H,Tsurumoto S

subject

Has Abstract

pub_date

1995-09-01 00:00:00

pages

2291-6

issue

5B

eissn

0250-7005

issn

1791-7530

journal_volume

15

pub_type

杂志文章
  • Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung.

    abstract:BACKGROUND:The frequency of epithelial cell adhesion molecule (EpCAM) expression was investigated in non-small cell lung cancer (NSCLC) cells and human tissues, and its clinicopathological significance in adenocarcinoma of the lung was evaluated. MATERIALS AND METHODS:EpCAM expression was analysed by reverse transcrip...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kim Y,Kim HS,Cui ZY,Lee HS,Ahn JS,Park CK,Park K,Ahn MJ

    更新日期:2009-05-01 00:00:00

  • The effect of diagnostic delay in patients with Hodgkin's lymphoma.

    abstract:BACKGROUND:The aim of the study was to document the delay in diagnosis of Hodgkin's disease (HD) and clarify the impact on clinical stage and survival in our region. MATERIAL AND METHODS:A retrospective study of the records of 50 patients treated for primary HD in northern-Norway in the time period 1985 - 1993 was per...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Norum J

    更新日期:1995-11-01 00:00:00

  • PS2 expression in BRCA1-associated breast cancers.

    abstract:BACKGROUND:PS2-expression is controlled by estrogens and is a prognostic factor for long-term and post-relapse survival. Breast carcinomas associated with a BRCA1 mutation (BRCA1-BC'S) exhibit many specific features, particularly for ER expression. Our purpose was to determine if pS2-expression was different in BRCA1-B...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Charafe-Jauffre E,Eisinger F,Mathoulin-Portier MP,Sobol H,Jacquemier J

    更新日期:2001-07-01 00:00:00

  • Influence of tamoxifen on the tumor content of steroid hormone receptors (ER, PgR and AR) in patients with primary breast cancer.

    abstract::A possible influence of tamoxifen (TAM) treatment on the measurable content of some steroid hormone receptors (i.e. ER, PgR, AR) from primary breast cancers has been evaluated. In eleven postmenopausal women, two biopsies were taken from the same tumor, the first biopsy before starting endocrine treatment, and a secon...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lundgren S,Søreide JA,Lea OA

    更新日期:1994-05-01 00:00:00

  • Radiation Gene-expression Signatures in Primary Breast Cancer Cells.

    abstract:BACKGROUND/AIM:In breast cancer (BC) care, radiation therapy (RT) is an efficient treatment to control localized tumor. Radiobiological research is needed to understand molecular differences that affect radiosensitivity of different tumor subtypes and the response variability. The aim of this study was to analyze gene ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12512

    authors: Minafra L,Bravatà V,Cammarata FP,Russo G,Gilardi MC,Forte GI

    更新日期:2018-05-01 00:00:00

  • Retinoic acid modulates RAR alpha and RAR beta receptors in human glioma cell lines.

    abstract::To identify retinoic acid (RA) signalling pathways involved in growth and differentiation in cells of the glial lineage, two human glioma ceh lines were studied. The three RA receptors (RARs) mRNAs were constitutively expressed, and of the three RXRs, RXR beta appeared predominant. Western blotting analysis confirmed ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Carpentier AF,Leonard N,Lacombe J,Zassadowski F,Padua RA,Degos L,Daumas-Duport C,Chomienne C

    更新日期:1999-07-01 00:00:00

  • Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: the role of Ureaplasma urealyticum.

    abstract:OBJECTIVE:To evaluate the existence of an association between cervicovaginal infections and precancerous lesions of the uterine cervix, through determination of prevalent cervicovaginal micro-organisms, alone and in association with human papillomavirus (HPV), in patients with abnormal and normal vaginal cytology. PAT...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lukic A,Canzio C,Patella A,Giovagnoli M,Cipriani P,Frega A,Moscarini M

    更新日期:2006-11-01 00:00:00

  • The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice.

    abstract::We have previously shown that oral administration of PSK not only exerts antitumor activity, but also restores immune response in tumor-bearing mice. In order to analyze the immunomodulative effect of PSK, we investigated the effects of oral PSK on the intestinal immune systems in ICR mice bearing sarcoma 180. Oral ad...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Matsunaga K,Morita I,Oguchi Y,Fujii T,Yoshikumi C,Nomoto K

    更新日期:1987-05-01 00:00:00

  • Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model.

    abstract:BACKGROUND/AIM:The aim of the present study was to determine the efficacy of trabectedin combined with FOLFIRI (irinotecan, leucovorin and 5-fluorouracil) on a colorectal cancer (CRC) patient-derived orthotopic xenograft (iPDOX) mouse model. MATERIALS AND METHODS:A CRC tumor from a patient previously established in nu...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13860

    authors: Zhu G,Zhao M,Han Q,Tan Y,Sun YU,Bouvet M,Clary B,Singh SR,Ye J,Hoffman RM

    更新日期:2019-12-01 00:00:00

  • Prophylactic brain irradiation: still an open question (review).

    abstract::Prophylactic cranial irradiation (PCI) is still an open question despite the fact that ten randomized trials have been published in the past, addressing its impact on overall survival, disease-free survival and incidence of brain recurrences. The majority of these trials allow us to conclude that PCI is only useful in...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Vitale V,Scolaro T,Orsatti M

    更新日期:1994-01-01 00:00:00

  • The p53-stabilizing compound, CP-31398, does not enhance chemosensitivity in human melanoma cells.

    abstract:BACKGROUND:Malignant melanoma is a life-threatening disease with a poor prognosis due to its capacity for rapid metastasis and resistance to radio- and chemo-therapy. A pharmacological compound, CP-31398, was recently found to be able to stabilize wild-type p53 and rescue mutant p53 to enhance its transcriptional activ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Luu Y,Li G

    更新日期:2003-01-01 00:00:00

  • Activity of bortezomib in glioblastoma.

    abstract:BACKGROUND:Chemotherapy is the commonly accepted standard therapy for most types of brain tumor, especially in medulloblastoma, primitive neuroectodermal tumor and astrocytoma. However, no efficient therapy has been established to date for glioblastoma multiforme. The aim of the present study was to analyze the activit...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Styczynski J,Olszewska-Slonina D,Kolodziej B,Napieraj M,Wysocki M

    更新日期:2006-11-01 00:00:00

  • Tumor and tissue distribution of 125I-labeled natural and antitumor antibodies in murine experimental tumor systems.

    abstract::The binding and tissue distribution of 125I-labeled rabbit anti-sarcoma 180 (S-180) immunoglobulin G (IgG) (RAS-180G), normal rabbit IgG (NRG) and ICR mouse IgGs from normal (NMG) and S-180-bearing ICR mice (AS-180G) were studied in ICR mice bearing S-180. 125I-labelled IgGs preparted from normal (NC57G) or Adenocarco...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Niimura K,Furusho T,Fujii M,Oguchi Y,Fujii T,Takahashi N,Matsunaga K,Sugita N,Yoshikumi C,Kawai Y

    更新日期:1988-07-01 00:00:00

  • Duration of adjuvant trastuzumab treatment in routine practice.

    abstract:BACKGROUND:Trastuzumab is used for the adjuvant (postoperative) treatment of (HER2)-positive early breast cancer. The duration of treatment is set at one year. The goal of our study was to examine the effective duration of trastuzumab treatment in routine clinical practice. PATIENTS AND METHODS:We performed a retrospe...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Montserrat M,Leveque D,Barthelemy P,Bergerat JP

    更新日期:2012-10-01 00:00:00

  • In vitro effects of heparin on SW480 tumor cell-matrix interaction.

    abstract::We investigated the in vitro effects of heparin on the growth and interaction of SW480 colon adenocarcinoma cells with the extracellular matrix proteins laminin, fibronectin and collagen IV. Cell adhesion assays were performed in wells precoated with the proteins mentioned. Tumor cell migration and invasiveness were a...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Antachopoulos CT,Iliopoulos DC,Gagos S,Agapitos MV,Karayannacos PE,Roboli SK,Skalkeas GD

    更新日期:1995-07-01 00:00:00

  • Thymidine kinase levels correlate with prognosis in aggressive lymphoma and can discriminate patients with a clinical suspicion of indolent to aggressive transformation.

    abstract::Serum levels of thymidine kinase 1 (TK1), an enzyme involved in the G1-S phase of the cell cycle, have been previously shown to correlate with the prognosis of lymphoid malignancies. We hypothesized that TK1 levels will be higher in aggressive, compared to indolent lymphoproliferative, malignancies and this may serve ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gatt ME,Goldschmidt N,Kalichman I,Friedman M,Arronson AC,Barak V

    更新日期:2015-05-01 00:00:00

  • Dehydroepiandrosterone sulfate estrogenic action at its physiological plasma concentration in human breast cancer cell lines.

    abstract::Estrogen receptor activation in hormone dependent cells (MCF-7 and T47D) and hormone independent cells (MDA-MB-231) was measured by bioluminescence in stably transfected human breast cancer MCF-7, T47D and MDA-MB-231 cell lines with a reporter gene which allows expression of the firefly luciferase enzyme under the con...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Le Bail JC,Allen K,Nicolas JC,Habrioux G

    更新日期:1998-05-01 00:00:00

  • From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives.

    abstract::Inflammatory bowel diseases (IBD) are associated with an increased risk of colitis-associated colorectal carcinoma (CAC). CAC is one of the most important causes of morbidity and mortality in patients with Crohn's disease and ulcerative colitis. The aim of the present review was to discuss the most important signaling...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Romano M,DE Francesco F,Zarantonello L,Ruffolo C,Ferraro GA,Zanus G,Giordano A,Bassi N,Cillo U

    更新日期:2016-04-01 00:00:00

  • Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV) non-Hodgkin's lymphoma.

    abstract::Pegylated liposomal doxorubicin is associated with a lower risk of cardiotoxocity than conventional formulations of doxorubicin, allowing the use of higher cumulative doses. In this Phase II study, 25 patients aged over 70 years (median 79, range 75-82 years) with aggressive non-Hodgkin's lymphoma (NHL) (International...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Tsavaris N,Kosmas C,Vadiaka M,Giannouli S,Siakantaris MP,Vassilakopoulos T,Pangalis GA

    更新日期:2002-05-01 00:00:00

  • Flow cytometric DNA and p53 analysis in superficially infiltrating bladder carcinoma.

    abstract::Mutations in the p53 gene occur frequently in bladder cancers. Better prognostic factors are needed to help select appropriate treatment for patients with TCC stage T1. Paraffin-embedded tumors from 73 patients with TCC stage T1 were processed for two-parameter flow cytometry, measuring both p53 protein and DNA. There...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Vatne V,Maartmann-Moe H,Hoestmark J

    更新日期:1994-11-01 00:00:00

  • Inositol hexakisphosphate and beta-cell stimulus-secretion coupling.

    abstract::Inositol hexakisphosphate (InsP6) inhibits serine/threonine protein phosphatases type-1 (PP1), type-2A (PP2A) and type-3 (PP3) in a concentration-dependent manner. Since the activity of voltage-gated L-type Ca(2+)-channels is increased by inhibition of serine/threonine protein phosphatases, this may explain trhe incre...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Barker CJ,Berggren PO

    更新日期:1999-09-01 00:00:00

  • MicroRNA Expression in KRAS- and BRAF-mutated Colorectal Cancers.

    abstract:BACKGROUND/AIM:KRAS and BRAF are two genes commonly mutated in colorectal cancer (CRC). Even though BRAF is a downstream target of KRAS in the MAPK signalling pathway, KRAS- and BRAF-mutated CRCs are found to display several different clinical and histopathological features. We investigated whether a differential expre...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12272

    authors: Lundberg IV,Wikberg ML,Ljuslinder I,Li X,Myte R,Zingmark C,Löfgren-Burström A,Edin S,Palmqvist R

    更新日期:2018-02-01 00:00:00

  • Vimentin 3 Expression in Prostate Cancer Cells.

    abstract:BACKGROUND/AIM:Vimentin3 (Vim3) was recently described as a tumour marker for the direct discrimination between benign and malignant kidney tumours. Here, we examined its expression in prostate cancer (PCa) cell lines and the regulation of its expression by endothelin receptors. MATERIALS AND METHODS:Prostate cancer c...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14762

    authors: KÖditz B,Stog A,GÖbel H,Heidegger I,Fries J,Heidenreich A,VON Brandenstein M

    更新日期:2021-01-01 00:00:00

  • Postoperative radiotherapy for localized prostate cancer: clinical significance of nadir prostate-specific antigen value within 12 months.

    abstract:AIM:To analyze retrospectively the results of postoperative radiotherapy for localized prostate cancer and to investigate the clinical significance of nadir prostate-specific antigen (PSA) value within 12 months (nPSA12) as an early estimate of clinical outcome after radiotherapy. PATIENTS AND METHODS:Seventy-six pati...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ogawa K,Nakamura K,Sasaki T,Onishi H,Koizumi M,Araya M,Mukumoto N,Mitsumori M,Teshima T,Japanese Patterns of Care Study Working Subgroup of Prostate Cancer.

    更新日期:2009-11-01 00:00:00

  • Interaction of radiation and etoposide on two cell lines with different radiosensitivities in vitro.

    abstract:PURPOSE:To investigate the differences between two rat yolk sac tumor cell lines with different radiosensitivities in etoposide sensitivity and in the sensitizing effect of etoposide in combination with irradiation. MATERIALS AND METHODS:NMT-1 is a parent radiosensitive cell line and NMT-1R is a variant radioresistant...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Takahashi T,Mitsuhashi N,Akimoto T,Matsumoto H,Ishikawa H,Saito Y,Niibe H

    更新日期:2003-07-01 00:00:00

  • Postoperative Exacerbation of Oxaliplatin-induced Neurotoxicity in Gastrointestinal Cancers: A Case Series.

    abstract:BACKGROUND/AIM:Oxaliplatin-induced neurotoxicity (OIN) can be severe and dose-limiting with clinically significant symptoms that persist for years. Few published reports have described postoperative exacerbation of OIN and more longitudinal data are needed to better characterize the phenomenon. PATIENTS AND METHODS:We...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14019

    authors: Gonzalez A,Walker EJ,Van Loon K,Cinar P,Atreya CE

    更新日期:2020-02-01 00:00:00

  • Up-regulation of glypican-3 in human hepatocellular carcinoma.

    abstract:AIM:To investigate the expression and significance of glypican-3 (GPC3) in human hepatocellular carcinoma (HCC). MATERIALS AND METHODS:DNA chips were used to measure the expression of mRNAs for members of the glypican and syndecan families of heparan sulfate proteoglycans (HSPGs) in normal liver tissue, non-tumor tiss...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Suzuki M,Sugimoto K,Tanaka J,Tameda M,Inagaki Y,Kusagawa S,Nojiri K,Beppu T,Yoneda K,Yamamoto N,Ito M,Yoneda M,Uchida K,Takase K,Shiraki K

    更新日期:2010-12-01 00:00:00

  • Uptake of Tc-99m MIBI related to tumour size and type.

    abstract::The accuracy of Tc-99m MIBI scintimammography depends on the uptake in cancer cells being greater than surrounding normal tissue. The aim of this study was to determine which were the dominant factors affecting uptake of Tc-99m MIBI in breast cancer cells in vivo. The tumour to background ratio (TBR) was measured in 7...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Buscombe JR,Cwikla JB,Thakrar DS,Hilson AJ

    更新日期:1997-05-01 00:00:00

  • A Case of Vanishing Brain Metastasis in a Melanoma Patient on Nivolumab.

    abstract:BACKGROUND:Melanoma is among the top three cancers to present with brain metastasis. The risk of brain metastases in advanced melanoma increases with disease duration. Cytotoxic chemotherapy does not have a significant role in the management of melanoma patients with brain metastases, neither alone nor in conjunction w...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11038

    authors: Basnet A,Saad N,Benjamin S

    更新日期:2016-09-01 00:00:00

  • The anticancer effect of 2'-3'-dehydrosalannol on triple-negative breast cancer cells.

    abstract:BACKGROUND:Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast tumors and these breast tumors are usually aggressive and highly metastatic. Unfortunately, treatment options for TNBCs are limited; we have identified a novel molecule, 2'-3'-dehydrosalannol (DHS) and in this study we investigated the an...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Boopalan T,Arumugam A,Damodaran C,Rajkumar L

    更新日期:2012-07-01 00:00:00